spezielle fachgebiete
Chondroitinsulfat
Literatur
1.Clegg DO, Reda DJ, Harris CL, et al: Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.N Engl J Med354(8):795-808, 2006. doi:10.1056/NEJMoa052771 2.Singh JA, Noorbaloochi S, MacDonald R, et al: Chondroitin for osteoarthritis.Cochrane Database Syst Rev1:CD005614, 2015. doi: 10.1002/14651858.CD005614.pub2 3.Honvo G, Bruyère O, Geerinck A, et al: Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials.Adv Ther36(5):1085-1099, 2019. doi:10.1007/s12325-019-00921-w 4.Hochberg M, Chevalier X, Henrotin Y, et al: Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?Curr Med Res Opin29(3): 259-267, 2013. doi: 10.1185/03007995.2012.753430 5.Reginster JY, Dudler J, Blicharski T, et al: Pharmaceutical-grade chondroitin sulfate is as effective ascelecoxiband superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versusCElecoxibversus Placebo Trial (CONCEPT).Ann Rheum Dis76(9):1537-1543, 2017. doi: 10.1136/annrheumdis-2016-210860 6.Kolasinski SL, Neogi T, Hochberg MC, et al: 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee [published correction appears in Arthritis Rheumatol. 2021 May;73(5):799].Arthritis Rheumatol72(2):220-233, 2020. doi:10.1002/art.41142 7.Bruyère O, Honvo G, Veronese N, et al: An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).Semin Arthritis Rheum49(3):337-350, 2019. doi:10.1016/j.semarthrit.2019.04.008 8.Volpi N: Chondroitin sulfate safety and quality.Molecules12;24(8), 2019. pii: E1447. doi: 10.3390/molecules24081447 9.Knudsen JF, Sokol GH: Potential glucosamine-warfarininteraction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.Pharmacotherapy28(4):540-548, 2008. doi: 10.1592/phco.28.4.540 